BETA

IPO registrations (S-1, F-1) · Registrants

ALLOS THERAPEUTICS INC

SEC CIK
1097264 · filings on EDGAR ↗
Name on the registration
ALLOS THERAPEUTICS
Former names
ALLOS THERAPEUTICS (2000–2002)
Registration
Form S-1, first filed 2000-01-26, last 2000-03-27; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 2000-03-28
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
11080 CIRCLEPOINT ROAD, SUITE 200, Westminster, CO 80020
EIN
54-1655029
EDGAR entity type
operating
Insiders and CEO pay
ALLOS THERAPEUTICS INC on the corporate pages

Offering terms

Proposed price range
$17.00–$19.00 per share (S-1/A filed 2000-03-27)
Final price
$18.00 per share, within the range (424B4 filed 2000-03-28, an initial public offering)
Shares sold
5,000,000
Gross proceeds
$90,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ALTH
Lead underwriters
Cowen
Syndicate
Prudential Securities; Piper Sandler

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2000-01-26S-1S-1 (registration)ALLOS THERAPEUTICS0001035704-00-000023 ↗
2000-03-02S-1/AS-1/A (amendment)ALLOS THERAPEUTICS0001035704-00-000118 ↗
2000-03-17S-1/AS-1/A (amendment)ALLOS THERAPEUTICS0000950134-00-002083 ↗
2000-03-27S-1/AS-1/A (amendment)ALLOS THERAPEUTICS0000950134-00-002390 ↗
2000-03-27S-1/AS-1/A (amendment)ALLOS THERAPEUTICS0001035704-00-000205 ↗
2000-03-28424B4424B4 (final prospectus)ALLOS THERAPEUTICS0000950134-00-002489 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-03-27S-1/Aregistration statement$17.00–$19.00$18.005,000,000$90,000,000Nasdaq ALTH3from the submission text; range, price sentence, shares headline, proceeds computed, cover names 3document ↗
2000-03-28424B4final prospectus$18.005,000,000$90,000,000Nasdaq ALTH3from the submission text; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Graboyes Marc HOfficerSVP, General Counsel; VP, General Counsel192006–2012
HERZIG MARKUS FOfficerVP Regulatory Affairs62006–2007
JOHNSON DOUGLAS GOfficerVP of Manufacturing182006–2008
Malek EricOfficerVP of Corporate Development42006–2007
Saunders Michael EOfficerVP, Clinical Development42006–2007
Clark David COfficerController; Principal Financial Officer; VP, Finance182006–2012
DELONG DAVID AOfficerVice President, Sales & Market12006
HOFFMAN STEPHEN JDirector; Director,OfficerChariman of the Board172006–2012
HART MICHAEL EDirector,Officer; OtherChief Executive Officer22006
BERNS PAUL LOfficerChief Executive Officer252006–2012
CASEY MICHAEL DDirector42006–2009
EDWARDS MARK GDirector12006
HEN STEWARTDirector62006–2010
LEFF JONATHAN SDirector112006–2012
LYNCH TIMOTHY PDirector72006–2011
JAFFE MARVINDirector12006
CARUSO JAMES VOfficerChief Commercial Officer152006–2010
14159 capital (GP), LLCTenPercentOwner132006–2009
Baker Biotech Capital (GP), LLCTenPercentOwner132006–2009
Baker Bros. Capital (GP), LLCTenPercentOwner122006–2009
Baker Brothers Life Sciences Capital (GP), LLCTenPercentOwner132006–2009
BAKER FELIXTenPercentOwner622006–2009
BAKER JULIANTenPercentOwner622006–2009
Baker / Tisch Capital (GP), LLCTenPercentOwner102006–2009
RINGO WILLIAM RDirector32007person page Fuzzy
CAGNONI PABLO JOfficerSr. VP, Chief Medical Officer72007–2009
LATTS JEFFREYDirector82007–2012
BENNETT BRUCE K JROfficerVP, Manufacturing; VP, Pharmaceutical Operations182008–2012
Warburg Pincus Private Equity VIII, L.P.Director,TenPercentOwner22008–2012
STOUT DAVID MDirector62009–2012
Morris Charles QOfficerChief Medical Officer112010–2012
DeSilva Nishan MDirector42010–2011
Goldsmith Bruce AOfficerSVP, Corporate Development; VP, Corporate Development92010–2012
Schick Michael EOfficerVP, Sales and Marketing112010–2012
GONZALO CECILIADirector32011–2012
TURNER JOSEPH LDirector32012
KAYE CHARLES RTenPercentOwner12012
Landy Joseph P.TenPercentOwner12012
OLER ABRAHAM N.OfficerPresident and Secretary12012
SAPPHIRE ACQUISITION SUB, INC.TenPercentOwner22012
SHAH BIMAL R.OfficerCFO and Treasurer12012
SPECTRUM PHARMACEUTICALS INCTenPercentOwner22012
WARBURG PINCUS & CO.Director,TenPercentOwner12012
WARBURG PINCUS LLCTenPercentOwner12012
Warburg Pincus Partners LLCDirector,TenPercentOwner12012

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationAllos Therapeutics, Inc.COState business registriesname and state
Business registrationALLOS THERAPEUTICS Inc.COState business registriesname and state
Business registrationALLOS THERAPEUTICS, INC.COState business registriesname and state
Plan sponsorALLOS THERAPEUTICS, INC.NVForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientALLOS THERAPEUTICS, INC.COFederal spending (USAspending)name and state
Patent assigneeALLOS THERAPEUTICS, INC.COPatents (USPTO)name and state
SEC filerALLOS THERAPEUTICS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerAllos Therapeutics, Inc.COTrademarks (USPTO)name and state
Form 5500 plan sponsorALLOS THERAPEUTICS, INC.EIN (EXACT)
Person pageWilliam R RingoPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CO first:

More with this interest.

In other datasets, the same topic (Health) in CO:

Interests: Pharmaceutical Preparations · Health